• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Variation in sensitivity of DNA synthesis to ara-C in acute myeloid leukaemia.

作者信息

Harris A L, Grahame-Smith D G

出版信息

Br J Haematol. 1980 Jul;45(3):371-9. doi: 10.1111/j.1365-2141.1980.tb07157.x.

DOI:10.1111/j.1365-2141.1980.tb07157.x
PMID:6932952
Abstract
摘要

相似文献

1
Variation in sensitivity of DNA synthesis to ara-C in acute myeloid leukaemia.急性髓细胞白血病中DNA合成对阿糖胞苷敏感性的差异。
Br J Haematol. 1980 Jul;45(3):371-9. doi: 10.1111/j.1365-2141.1980.tb07157.x.
2
Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
Semin Oncol. 1985 Jun;12(2 Suppl 3):1-8.
3
Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia.
Blood. 1987 Apr;69(4):1134-40.
4
Effects of cytosine arabinoside on DNA synthesis as predictor for acute myelocytic leukemia (AML) patients' response to chemotherapy.
Eur J Cancer (1965). 1981 Jun;17(6):623-8. doi: 10.1016/0014-2964(81)90264-4.
5
Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.接受1-β-D-阿拉伯呋喃糖基胞嘧啶治疗的患者骨髓和外周血白血病细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的定量分析。
Cancer Res. 1980 Mar;40(3):588-91.
6
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
Clin Sci (Lond). 1981 Feb;60(2):191-8. doi: 10.1042/cs0600191.
7
Inhibition by arabinosylcytosine of DNA synthesis in bone marrows of relapsed AML patients.阿糖胞苷对复发急性髓系白血病患者骨髓中DNA合成的抑制作用。
Eur J Cancer (1965). 1979 Oct;15(10):1263-8. doi: 10.1016/0014-2964(79)90252-4.
8
An in vitro model to predict clinical response in adult acute myelogenous leukemia.一种预测成人急性髓性白血病临床反应的体外模型。
Semin Oncol. 1987 Jun;14(2 Suppl 1):172-81.
9
Treatment of relapsed or refractory AML with intermediate-dose arabinosylcytosine (ara-C): confirmation of the importance of ara-C triphosphate formation in mediating response to ara-C.用中剂量阿糖胞苷（ara-C）治疗复发或难治性急性髓系白血病（AML）：证实阿糖胞苷三磷酸形成在介导对阿糖胞苷反应中的重要性。
Leuk Lymphoma. 1993;10 Suppl:115-21. doi: 10.3109/10428199309149123.
10
Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.去磷酸化在人淋巴细胞系中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸积累中的作用及其与药物敏感性的关系
Cancer Res. 1982 Jul;42(7):2846-51.

引用本文的文献

1
Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs.正常犬口服阿糖胞苷磷酸酯的药代动力学和白细胞生物标志物评估。
J Vet Intern Med. 2023 Nov-Dec;37(6):2429-2442. doi: 10.1111/jvim.16842. Epub 2023 Sep 5.
2
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.肿瘤治疗中嘧啶类似物的细胞内药代动力学及其与药物作用的相关性。
Clin Pharmacokinet. 2020 Dec;59(12):1521-1550. doi: 10.1007/s40262-020-00934-7.
3
Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemia.
氟达拉滨联合中剂量阿糖胞苷与高剂量阿糖胞苷作为急性髓系白血病巩固治疗的回顾性比较
Medicine (Baltimore). 2014 Dec;93(27):e134. doi: 10.1097/MD.0000000000000134.
4
The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia.阿糖胞苷体外代谢与急性髓系白血病治疗反应的关系。
Cancer Chemother Pharmacol. 1982;9(1):30-5. doi: 10.1007/BF00296758.
5
Clinical trial of low-dose Ara-C in the treatment of acute leukemia and myelodysplasia.小剂量阿糖胞苷治疗急性白血病和骨髓增生异常综合征的临床试验。
Blut. 1984 May;48(5):255-61. doi: 10.1007/BF00320395.
6
In vitro exposure of leukemic cells to low concentration Arabinosyl Cytosine: no evidence of differentiation inducing activity.白血病细胞在体外暴露于低浓度阿糖胞苷：无诱导分化活性的证据。
Blut. 1987 May;54(5):299-306. doi: 10.1007/BF00320878.
7
Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.N4-棕榈酰-1-β-D-阿拉伯呋喃糖基胞嘧啶在血液系统恶性肿瘤患者中的临床药理学
Cancer Chemother Pharmacol. 1989;24(6):371-5. doi: 10.1007/BF00257445.
8
Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine.
Cancer Chemother Pharmacol. 1991;27(4):258-62. doi: 10.1007/BF00685109.
9
Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside.
Cancer Chemother Pharmacol. 1992;29(3):173-7. doi: 10.1007/BF00686248.